These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17652236)

  • 1. Tobacco industry lawyers as "disease vectors".
    Guardino SD; Daynard RA
    Tob Control; 2007 Aug; 16(4):224-8. PubMed ID: 17652236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lawyer control of internal scientific research to protect against products liability lawsuits. The Brown and Williamson documents.
    Hanauer P; Slade J; Barnes DE; Bero L; Glantz SA
    JAMA; 1995 Jul; 274(3):234-40. PubMed ID: 7609232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
    Tan CE; Kyriss T; Glantz SA
    PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
    Douglas CE; Davis RM; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Playing hide-and-seek with the tobacco industry.
    LeGresley EM; Muggli ME; Hurt RD
    Nicotine Tob Res; 2005 Feb; 7(1):27-40. PubMed ID: 15804675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Product liability.
    Daynard RA; Legresley E
    Tob Control; 2012 Mar; 21(2):227-8. PubMed ID: 22345254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.
    Davis RM; Douglas CE; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv4-8. PubMed ID: 17130623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest.
    Bitton A; Neuman MD; Barnoya J; Glantz SA
    Lancet; 2005 Feb 5-11; 365(9458):531-40. PubMed ID: 15705463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Litigation in Argentina: challenging the tobacco industry.
    Flores ML; Barnoya J; Mejia R; Alderete E; Pérez-Stable EJ
    Tob Control; 2006 Apr; 15(2):90-6. PubMed ID: 16565455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking through a keyhole at the tobacco industry. The Brown and Williamson documents.
    Glantz SA; Barnes DE; Bero L; Hanauer P; Slade J
    JAMA; 1995 Jul; 274(3):219-24. PubMed ID: 7609230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big tobacco is watching: British American Tobacco's surveillance and information concealment at the Guildford depository.
    Muggli ME; LeGresley EM; Hurt RD
    Lancet; 2004 May; 363(9423):1812-9. PubMed ID: 15172782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of British American Tobacco's questionable use of privilege and protected document claims at the Guildford Depository.
    LeGresley E; Lee K
    Tob Control; 2017 May; 26(3):316-322. PubMed ID: 27354678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.
    Hammond D; Chaiton M; Lee A; Collishaw N
    CMAJ; 2009 Nov; 181(10):691-8. PubMed ID: 19828670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
    Cummings KM; Morley CP; Hyland A
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco control implications of the first European product liability suit.
    Hiilamo HT
    Tob Control; 2005 Feb; 14(1):22-30. PubMed ID: 15735296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents.
    Bero L; Barnes DE; Hanauer P; Slade J; Glantz SA
    JAMA; 1995 Jul; 274(3):241-7. PubMed ID: 7609233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.
    Velicer C; Lempert LK; Glantz S
    Tob Control; 2015 Sep; 24(5):469-80. PubMed ID: 24920577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tobacco Industry's Abuse of Scientific Evidence and Activities to Recruit Scientists During Tobacco Litigation.
    Lee S
    J Prev Med Public Health; 2016 Jan; 49(1):23-34. PubMed ID: 26841882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco industry influence on the definition of tobacco related disorders by the American Psychiatric Association.
    Neuman MD; Bitton A; Glantz SA
    Tob Control; 2005 Oct; 14(5):328-37. PubMed ID: 16183984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.